Literature DB >> 10759762

Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice.

E F Verdù1, P Bercik, B Cukrowska, M A Farre-Castany, H Bouzourene, E Saraga, A L Blum, I Corthésy-Theulaz, H Tlaskalova-Hogenova, P Michetti.   

Abstract

Homeostasis between indigenous intestinal flora and host response may be broken in inflammatory bowel disease. The present study explores whether repeated oral administration of intestinal flora antigens can protect mice against dextran sodium sulphate (DSS)-induced colitis. Sonicates of Gram-positive, Gram-negative, or anaerobic resident bacteria isolated from mouse intestinal flora were fed to BALB/c mice by gastric gavage, with or without cholera toxin. After four weekly doses of 1 mg of these antigen preparations (or of PBS as control), DSS colitis was induced. One week later colitis was evaluated by clinical scores and histology. Mice fed a pool of the three sonicates had decreased inflammation scores (5 (1-14); median (range)) compared with PBS-fed control animals (15 (7-19); P < 0.05). Decreased inflammation was observed in mice fed anaerobic bacteria antigens (7 (6-11); P < 0.05 versus control), but not in mice fed a pool of Gram-positive and -negative sonicates (16 (12-16)). Inflammation scores of mice fed antigens with cholera toxin were similar to those of PBS-fed control animals. DSS-induced colitis can be suppressed by oral administration of normal intestinal flora antigens containing anaerobes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759762      PMCID: PMC1905615          DOI: 10.1046/j.1365-2249.2000.01170.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

Authors:  S R Targan; S B Hanauer; S J van Deventer; L Mayer; D H Present; T Braakman; K L DeWoody; T F Schaible; P J Rutgeerts
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

2.  Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.

Authors:  G R D'Haens; K Geboes; M Peeters; F Baert; F Penninckx; P Rutgeerts
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

Review 3.  Oral tolerance: immune mechanisms and treatment of autoimmune diseases.

Authors:  H L Weiner
Journal:  Immunol Today       Date:  1997-07

4.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.

Authors:  H C Rath; H H Herfarth; J S Ikeda; W B Grenther; T E Hamm; E Balish; J D Taurog; R E Hammer; K H Wilson; R B Sartor
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

5.  Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man.

Authors:  S L Gorbach; L Nahas; P I Lerner; L Weinstein
Journal:  Gastroenterology       Date:  1967-12       Impact factor: 22.682

6.  Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice.

Authors:  L G Axelsson; E Landström; T J Goldschmidt; A Grönberg; A C Bylund-Fellenius
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

7.  Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.

Authors:  C O Elson; K W Beagley; A T Sharmanov; K Fujihashi; H Kiyono; G S Tennyson; Y Cong; C A Black; B W Ridwan; J R McGhee
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

Review 8.  Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.

Authors:  R B Sartor
Journal:  Gastroenterol Clin North Am       Date:  1995-09       Impact factor: 3.806

9.  Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group.

Authors:  S J van Deventer; C O Elson; R N Fedorak
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

10.  Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.

Authors:  M F Neurath; I Fuss; B L Kelsall; D H Presky; W Waegell; W Strober
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

View more
  18 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches.

Authors:  Thomas W Spahn; Hermann Herbst; Paul D Rennert; Norbert Lügering; Christian Maaser; Mathias Kraft; Adriano Fontana; Howard L Weiner; Wolfram Domschke; Torsten Kucharzik
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation.

Authors:  Mélanie G Gareau; Jennifer Jury; Glenda MacQueen; Philip M Sherman; Mary H Perdue
Journal:  Gut       Date:  2007-03-05       Impact factor: 23.059

4.  Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice.

Authors:  A Kokesová; L Frolová; M Kverka; D Sokol; P Rossmann; J Bártová; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

5.  Intravenous injection of endogenous microbial components abrogates DSS-induced colitis.

Authors:  Beate C Sydora; Eric J Albert; Rae R Foshaug; Jason S G Doyle; Thomas A Churchill; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2011-09-01       Impact factor: 3.199

6.  Oral administration of unmodified colonic but not small intestinal antigens protects rats from hapten-induced colitis.

Authors:  A Dasgupta; K V Kesari; K K Ramaswamy; P S Amenta; K M Das
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

7.  Tapeworm infection reduces epithelial ion transport abnormalities in murine dextran sulfate sodium-induced colitis.

Authors:  C Reardon; A Sanchez; C M Hogaboam; D M McKay
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

8.  Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria.

Authors:  Sonia Pavan; Pierre Desreumaux; Annick Mercenier
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

Review 9.  Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders.

Authors:  G A W Rook; V Adams; J Hunt; R Palmer; R Martinelli; L Rosa Brunet
Journal:  Springer Semin Immunopathol       Date:  2003-10-08

Review 10.  Role of Nod2 in the development of Crohn's disease.

Authors:  Soichiro Yamamoto; Xiaojing Ma
Journal:  Microbes Infect       Date:  2009-06-30       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.